The metabolism of labelled hexadecyl sulphate salts in the rat, dog and human.
The metabolic fate of [1-14-C]hexadecylsulphate and hexadecyl[35-S]sulphate, administered intravenously as the sodium and trimethylammonium salt to dogs and orally as the erythromycin salt to dogs, rats and humans, was studied. Studies with rats indicated that the compounds were well absorbed and rapidly excreted in the urine. However, after oral administration of the 14-C-and 35-S-labelled hexadecyl sulphate erythromycin salt to dogs, considerable amounts of radioactivity were excreted in the faeces as unmetabolized hexadecyl sulphate. Studies with two humans showed that orally administered erythromycin salt of [1-14C]hexadecyl sulphate was well absorbed in one person but poorly absorbed in the other. Radioactive metabolites in urine were separated by t.l.c. in two solvent systems. The main metabolite of hexadecyl sulphate in the dog, rat and human was identified as the sulphate ester of 4-hydroxybutyric acid. In addition, psi-[14-C]butyrolactone as a minor metabolic product of [1-14-C]hexadecyl sulphate was also isolated from the urine of rat, dog and man. However, there was still another metabolite in dog urine, which comprised about 20% of the total urinary radioactivity and carried both 14-C and 35-S labels. This metabolite was absent from rat urine. The metabolite in dog urine was isolated and subsequently identified by t.l.c. and g.l.c. and by isotope-dilution experiments as the sulphate ester of glycollic acid. Small amounts (about 5% of the total recovered radioactivity in excreta) of labelled glycollic acid sulphate were also found in human urine after ingestion of erythromycin [1-14-C]hexadecyl sulphate.
D000284:Administration, Oral; D000818:Animals; D004285:Dogs; D004917:Erythromycin; D005243:Feces / Q000737:chemistry; D005260:Female; D006801:Humans; D006885:Hydroxybutyrates / Q000378:metabolism; D007275:Injections, Intravenous; D008297:Male; D010168:Palmitates / Q000008:administration & dosage / Q000378:metabolism* / Q000652:urine; D010169:Palmitic Acids / Q000378:metabolism*; D000644:Quaternary Ammonium Compounds / Q000378:metabolism; D051381:Rats; D013431:Sulfates / Q000378:metabolism* / Q000652:urine; D013997:Time Factors
D006885:Hydroxybutyrates; D010168:Palmitates; D010169:Palmitic Acids; D000644:Quaternary Ammonium Compounds; D013431:Sulfates; D004917:Erythromycin